Sep 27, 2021 / 12:40PM GMT
Charles Cliff Duncan - Cantor Fitzgerald & Co., Research Division - Senior Analyst
Hello. Good morning, and welcome to the Cantor Global Healthcare Conference for 2021. My name is Charles Duncan. I'm a Managing Director and Senior Biotechnology Analyst with the firm's Equity Research Department. And this is day 1 of the Cantor Conference. And I have to say, what a year it has been since we last hosted our clients in the fall of 2020.
So it's a pleasure to introduce the next -- actually, the first presenting speaker for me. This is KalVista Pharmaceuticals. KalVista is an interesting platform-enabled drug developer, and I -- it's a pleasure to introduce the company's CEO, Dr. Andrew Crockett. I also have Mr. Ben Palleiko, the company's CFO and CBO with me today; and Dr. Chris Yea, the company's Chief Development Officer. Gentlemen, good morning. How are you?
Thomas Andrew Crockett - KalVista Pharmaceuticals, Inc. - CEO & Director
Chaz, thanks for having us today.
Christopher M. Yea - KalVista Pharmaceuticals, Inc. -
Kalvista Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript
Sep 27, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers